ReviewJournal of the Endocrine Society2026
Antimony: a cryptic metabolism disruptor ubiquitous in food contact materials.
Review in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Engineered Activated Carbons for Multi-Radionuclide Removal from Real Low-Level Radioactive Wastewater.Nanomaterials (Basel, Switzerland) · 2026Article
- Plasticizing Diabetes Care: The Metabolic Threat of Plastic-Associated Endocrine Disruptors and Micro-/Nanoplastics in Clinical Medicine.Current diabetes reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimony (Sb) is a group 15 metalloid that is used as a catalyst in the production of polyethylene terephthalate (PET) plastic, a common food contact material (FCM). PET accounts for over 44% of single-use beverage packaging units and is also used in the production of food trays, storage containers, and other items. Due to its frequent co-occurrence with other metals, Sb is also a common contaminant in crystalware, ceramics, and metal FCMs. In light of the increasing use of Sb-containing FCMs in modern society, a thorough evaluation of Sb's potential effect on public health is warranted. Burgeoning evidence suggests Sb is linked to common cardiometabolic conditions, including dyslipidemia, obesity, diabetes, hypertension, heart failure, and atherosclerotic cardiovascular disease. Thus, this review aims to (1) perform a comprehensive systematic assessment of Sb migration from FCMs into foodstuffs and food simulants, (2) obtain an overview of antimony-related health risks, and (3) inform the generation of harm-reduction guidelines at the individual and systems levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.